Overall survival data from EMBARK trial support enzalutamide plus leuprolide as standard of care.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/enzalutamide-extends-survival-high-risk-prostate-cancer-2025a1000sk5?src=rss
Author :
Publish date : 2025-10-21 14:48:00
Copyright for syndicated content belongs to the linked Source.
